LEDGER
Portfolio
← All instruments

PG

SP100NYSE

The Procter & Gamble Company

Consumer Defensive · Household & Personal Products · United States

$145.98
+0.90% today
Mkt Cap
$339.32B
P/E
22.02×
Fwd P/E
19.73×
Div Yield
2.98%
Beta
0.377×
52W Range
28.2%
Company profileSource: provider

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

www.pginvestor.com
By the numbersComputed from live metrics

Shares trade at a moderate 22.1× trailing earnings, easing to 21.4× on forward estimates. Profitability shows a net margin of 19.2% and return on equity of 31.1%. Leverage is modest at 1.0× net debt/EBITDA. Revenue grew 7.4% year-on-year. It yields 2.8% in dividends. The mean analyst target of USD163.43 sits 7.9% above the current price (Buy, 23 analysts).

AI analysisAI-generated · 04 Jul 2026 · claude-opus (research)

business model

Procter & Gamble is a global consumer packaged-goods company that develops, manufactures, and markets branded household and personal-care products. It generates revenue by selling everyday-use branded products through retail, e-commerce, and distributor channels, emphasizing premiumization, innovation, and brand marketing to sustain pricing power.

revenue segments

Revenue is organized into five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Fabric & Home Care and Baby, Feminine & Family Care are among the largest contributors, anchored by brands such as Tide, Pampers, Gillette, Pantene, and Crest.

key dependencies

Depends on brand equity, retailer shelf placement and relationships, commodity and freight input costs, marketing effectiveness, and consumer willingness to pay premiums. Innovation cadence and scale in R&D and distribution are important to defending share against private label.

competitors

Competes with Unilever, Colgate-Palmolive, Kimberly-Clark, Church & Dwight, Henkel, Reckitt, L'Oreal, and Estee Lauder in beauty, along with growing private-label and direct-to-consumer challengers across categories.

moat

Its moat comes from a portfolio of leading, trusted brands, enormous scale in manufacturing and distribution, advertising reach, and continuous product innovation that supports premium pricing and shelf dominance. Retailer relationships and category leadership reinforce the advantage.

risks

Risks include commodity and currency headwinds, private-label competition and consumer trade-down during economic stress, exposure to slowing categories, retailer bargaining power, and the need to keep innovating to justify premium pricing. Large international exposure adds foreign-exchange volatility.

01

Financials & metrics

as of 26 Aug 2026
52-week rangeNear 52-week low · 28%
Low $137.62Now $145.98High $167.25

Price is closer to the low end of its range. Green = nearer the yearly low, red = nearer the high — a position indicator, not a buy/sell signal.

Valuation
Profitability
Growth
Financial Health
Efficiency
Cash Flow
Per Share
Dividend
Market

Tap any metric for an explanation. provider computedN/A not available from source

Profit & loss · annual (USD)latest net margin 18.4%
📈

Valuation history is being recorded

We snapshot P/E and price targets daily. This chart fills in over the coming days.

Full financial statements

Income statement

Line item20262025202420232022
Total revenue$87.03B$84.28B$84.04B$82.01B
Cost of revenue$43.36B$41.16B$40.85B$42.76B
Gross profit$43.67B$43.12B$43.19B$39.25B
Operating expense$23.92B$22.67B$23.30B$21.11B
Operating income$19.75B$20.45B$19.89B$18.13B
Interest expense$877.00M$907.00M$925.00M$756.00M
Pretax income$20.38B$20.17B$18.76B$18.35B
Tax provision$4.23B$4.10B$3.79B$3.62B
Net income$16.05B$15.97B$14.88B$14.65B
EBITDA$24.41B$23.92B$22.58B$21.82B
Diluted EPS$6.62$6.51$6.02$5.90

Balance sheet

Line item20262025202420232022
Total assets$126.52B$125.23B$122.37B$120.83B
Current assets$26.21B$25.39B$24.71B$22.65B
Cash & equivalents$9.94B$9.56B$9.48B$8.25B
Inventory$8.17B$7.55B$7.02B$7.07B
Total liabilities$72.21B$72.95B$71.81B$73.76B
Current liabilities$38.69B$36.06B$33.63B$35.76B
Total debt$35.03B$35.46B$33.37B$35.42B
Long-term debt$22.84B$25.00B$25.27B$24.38B
Shareholders' equity$54.08B$52.01B$50.29B$46.78B
Retained earnings$135.85B$129.97B$123.81B$118.17B
Working capital-$12.49B-$10.67B-$8.92B-$13.11B

Cash flow

Line item20262025202420232022
Operating cash flow$19.56B$17.82B$19.85B$16.85B
Investing cash flow-$4.62B-$3.82B-$3.50B-$3.50B
Financing cash flow-$14.46B-$14.04B-$14.86B-$12.15B
Capital expenditure-$4.41B-$3.77B-$3.32B-$3.06B
Free cash flow$15.15B$14.04B$16.52B$13.79B
Dividends paid-$10.23B-$9.87B-$9.31B-$9.00B
Share buybacks-$5.03B-$6.50B-$5.01B-$7.35B
End cash position$9.94B$9.56B$9.48B$8.25B

Reported figures from public filings via Yahoo Finance. Line coverage varies by company. Not investment advice.

02

Dividends

Dividend Yield
2.98%
Annual Rate
$4.35
Payout Ratio
64.3%
Frequency
Quarterly
Latest ex-date
24 Jul 2026
Pay date
17 Aug 2026
Most recent
$1.09
Dividend history · per payment (USD)
03

Analyst assessment

as of 26 Aug 2026
Buy23 analysts
Implied to mean target
+10.0%
Low $143.00High $186.00
Now
$145.98
Low
$143.00
Mean
$160.57
High
$186.00
Rating distribution
Strong Buy 6
Buy 7
Hold 12
Sell 0
Strong Sell 0

Aggregate consensus only. Named per-analyst targets require a premium source and are not shown; the data model is ready to hold them if one is added.

04

Technicals

as of 26 Aug 2026
CloseSMA 50SMA 200Death cross
SMA 50
$147.21
SMA 200
$147.58
RSI (14)
41.7
MACD
-0.64
RSI (14) · overbought > 70 · oversold < 30
05

News

Estee Lauder Stock Jumped On A Bigger Margin Promise
The beauty group's repricing rests on a profit plan it controls, while the low end of its new sales guidance is no faster than the year just ended.
Trefis · 4d ago
Read ↗
3 Dividend Stocks to Buy Before August Ends and Hold for Life
While speculation runs hot and patience gets punished, three Dividend Kings with unbroken raise streaks spanning decades just posted results that made long-term holders take notice, and two of them are sitting at rare discounts heading into September.
24/7 Wall St. · 5d ago
Read ↗
This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.
Perrigo makes private-label over-the-counter drugs, which sounds like a reliable business, but there are warning signs to consider before you buy it.
Motley Fool · 6d ago
Read ↗
Is P&G’s Everyday Innovation Push With Charmin and Swiffer Quietly Shaping Its Brand Moat (PG)?
In recent weeks, Procter & Gamble’s Charmin and Swiffer brands rolled out new consumer products and campaigns, including the Charmin Forever Roll “Roommate Trials” initiative and the Swiffer Hair Magnet launch with hair expert Jen Atkin. These moves highlight how P&G continues to refresh mature household categories through marketing-led innovation aimed at everyday pain points in shared living and home cleaning. We’ll now examine how P&G’s focus on everyday product innovation, exemplified by...
Simply Wall St. · 7d ago
Read ↗
How GOJO Could Shape Clorox's Fiscal 2027 Growth and Margin Outlook
CLX's GOJO deal boosts fiscal 2027 sales, but inflation, acquisition costs and margin pressure could limit underlying growth.
Zacks · 7d ago
Read ↗
Is Clorox Stock Worth Buying as GOJO Growth Meets Margin Pressure?
CLX's GOJO-led growth faces margin pressure, muted core demand and inflation risks, leaving investors focused on a durable recovery.
Zacks · 7d ago
Read ↗
Clorox Stock Jumps 13.1% in a Month. Can the Gains Keep Building?
CLX's rebound faces margin pressure, muted underlying demand and weaker earnings revisions despite GOJO and ERP tailwinds.
Zacks · 7d ago
Read ↗
Colgate Raises 2026 Profit Outlook After Q2 Earnings Beat and Margin Gains
CL raised its 2026 profit outlook after a Q2 earnings beat and 140-basis-point margin gain, while higher costs and North America remain risks.
Zacks · 7d ago
Read ↗
Is Colgate Stock a Buy as Growth Improves but Valuation Stays Rich?
CL enters the second half with better volumes, resilient margins and a higher earnings outlook, but rich valuation and U.S. weakness temper the upside.
Zacks · 7d ago
Read ↗
Looking to Generate Passive Income From Stocks? 3 Magnificent High-Yield Dividend Stocks to Buy Now
Three Dividend Kings with 50-plus years of raises could pay you for decades.
Motley Fool · 7d ago
Read ↗
The Best Dividend Stock for 2027 and Beyond: Procter & Gamble
The 3% dividend yield doesn't tell the whole story.
Motley Fool · 7d ago
Read ↗
Walmart Just Posted Its Weakest US Sales Growth in Six Years: 2 Dividend Kings Built for a Squeezed Consumer
Walmart just flashed a consumer stress signal that income investors cannot afford to ignore, and two Dividend Kings with decades of unbroken payout growth may be the only safe harbor left for retirees watching their portfolio checks.
24/7 Wall St. · 8d ago
Read ↗
3 Reasons to Buy and Hold This Wide-Moat Dividend King's Stock Forever
It's rare for any company to be able to remain in a position to dominate its markets. This one is a compelling exception.
Motley Fool · 9d ago
Read ↗
P&G’s (PG) $3.8B Wellness Deal Collides With a Costly Outlook
Procter & Gamble (NYSE:PG) is buying its way into wellness. On August 4, L Catterton announced it had signed a definitive agreement to sell Thorne, a science-backed health and wellness brand, to Procter & Gamble for $3.8 billion in cash. The deal lands a day after an August 3 analysis flagged a fiscal 2027 earnings […]
Insider Monkey · 19d ago
Read ↗
Wall Street Is Betting P&G’s Dividend Growth Ends. The Cash Flow Suggests That’s Not Happening
Procter & Gamble just logged its 70th consecutive dividend increase, yet Wall Street has turned skeptical, pointing to tariff costs, margin compression, and guidance at the lower end of its range. The cash flow statement is telling a completely different story.
24/7 Wall St. · 19d ago
Read ↗
What Could Procter & Gamble (PG) Chairman Change Mean After Jon Moeller Retires?
Procter & Gamble (NYSE:PG) appointed Shailesh Jejurikar as Chairman of the Board, succeeding Jon R. Moeller following his retirement after 38 years at the company. The board transition shifts leadership at the top of Procter & Gamble’s governance structure as Moeller steps down from his role as Executive Chairman. Investors are watching the handover closely, given the potential long term implications for company culture, operations, and board oversight. For readers tracking long term...
Simply Wall St. · 20d ago
Read ↗
How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62
A $425,000 nest egg can generate wildly different monthly paychecks depending on where you put it, but chasing the biggest number often destroys the very asset you need to last through your 70s.
24/7 Wall St. · 20d ago
Read ↗
How Much Do You Need Invested to Out-Earn the Average Social Security Check With Dividends?
Replicating a Social Security check with dividends sounds straightforward until you realize the yield you chase determines whether your income grows, stalls, or quietly disappears over the next two decades.
24/7 Wall St. · 20d ago
Read ↗
Why PG, JNJ, and KO Could Surprise Investors Next Year
Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensive investors heading into 2027.
24/7 Wall St. · 20d ago
Read ↗
The Portfolio Blueprint for Building $50,000 a Month in Dividend Income
Chasing a $50,000 monthly dividend stream sounds like a math problem, but the yield you pick determines whether your portfolio funds four decades of freedom or quietly cannibalizes itself while the checks keep arriving.
24/7 Wall St. · 21d ago
Read ↗
06

Sector peers

Other Consumer Defensive names by market cap.

Compare side by side →
CompanyPriceMkt capP/EUpside
WMTWalmart Inc.$104.95$835.20B38.0+48%
COSTCostco Wholesale Corporation$967.46$429.05B48.6+36%
KOThe Coca-Cola Company$92.00$395.84B27.6+13%
PMPhilip Morris International Inc.$192.86$300.59B26.5+17%
PEPPepsiCo, Inc.$145.07$198.16B19.0+26%
MOAltria Group, Inc.$68.56$114.47B14.4+20%
07

Notes & alerts

Sign in to keep a private research note and set price alerts for PG.